Harmony Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Harmony Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Dierks Jeffrey
Harmony Biosciences | 8-K: Current report
Harmony Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Harmony Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Dierks Jeffrey
Harmony Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Harmony Biosciences | 8-K: HARMONY BIOSCIENCES REPORTS STRONG SECOND QUARTER 2024 FINANCIAL RESULTS AND ADVANCES PITOLISANT HIGH-DOSE PROGRAM TOWARD EXPECTED PDUFA DATE IN 2028
Harmony Biosciences | 10-Q: Q2 2024 Earnings Report
Harmony Biosciences | 8-K: Current report
Harmony Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Sender Gary
Harmony Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Gracias Antonio J.
Harmony Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Sabater Juan A.
Harmony Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Graf R. Mark
Harmony Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Nielsen Jack
Harmony Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Szyper Linda M
Harmony Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Anastasiou Peter
Harmony Biosciences | 8-K: Current report
Harmony Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Budur Kumar
Harmony Biosciences | 8-K: Current report
Harmony Biosciences | 10-Q: Q1 2024 Earnings Report
No Data
No Data